MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹97 Cr | ₹300 Cr | ₹5.20 Cr | ₹144 Cr | ₹66 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹97 Cr |
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹5.20 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹66 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹97 Cr | -67.52 | |
| Mar2025 | ₹300 Cr | 5,661.50 | |
| Mar2024 | ₹5.20 Cr | -96.37 | |
| Mar2023 | ₹144 Cr | 116.39 | |
| Mar2022 | ₹66 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,195.0 Cr | -4.3% | -24.5% | 115.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -4.3% |
-24.5% |
115.2% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses